Susan P Mollan1,2,3, David Spitzer4, David J Nicholl5,6. 1. Birmingham Neuro-Ophthalmology Unit, University Hospitals Birmingham NHS Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham, UK susan.mollan@uhb.nhs.uk. 2. Metabolic Neurology, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. 3. Institute of Translational Medicine, Birmingham Health Partners, University of Birmingham, UK. 4. PHGH Doctors, Temple Fortune Medical Centre, London, UK. 5. Department of Neurology, City Hospital, Birmingham, UK. 6. Department of Neurology, University Hospitals Birmingham NHS Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham, UK.
Authors: Shannon M Fernando; Alexandre Tran; Wei Cheng; Bram Rochwerg; Monica Taljaard; Kwadwo Kyeremanteng; Shane W English; Mypinder S Sekhon; Donald E G Griesdale; Dar Dowlatshahi; Victoria A McCredie; Eelco F M Wijdicks; Saleh A Almenawer; Kenji Inaba; Venkatakrishna Rajajee; Jeffrey J Perry Journal: BMJ Date: 2019-07-24
Authors: Olivia Grech; Susan P Mollan; Benjamin R Wakerley; Zerin Alimajstorovic; Gareth G Lavery; Alexandra J Sinclair Journal: J Neurol Date: 2020-07-22 Impact factor: 4.849